|
|
|
|
http://www.barrlabs.com/overview/annual/BRL_AR2002.pdf
Research and devel pment resulted in a rec rd number f new pr duct appr vals that expanded ur fferings in key therapeutic categ ries.
7 million in fiscal 2002.
25 1.
This agreement will permit us to introduce a generic version of this product under a non- exclusive license agreement in January 200 , nine months prior to the patent expiration.
Flutamide Capsules, the...
|
|
|
http://www.barrlabs.com/overview/annual/BRL_AR2002.pdf page 16
|
|
|
http://www.barrlabs.com/overview/annual/BRL_AR2002.pdf page 15
|
|
|
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
|
|
|
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
|
|
|
Index F, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - INDEX - Index-A -~ Index-B -~ Index-C -~ Index-D -~ Index-E -~ Index-F-~ Index-G -~ Index-H -~ Index-I -~ Index-J -~ Index-K -~ Index-L -~ Index-M -~ Index-N -~ Index-O ...
|
|
|
Index: FL: Merck Manual Home Edition
Flow rate (lung) Using a Spirometer Flow volume (lung) Diagnosis: Flow Volume Testing Flu respiratory see Influenza stomach see Gastroenteritis Fluconazole Drugs for Serious Fungal Infections Flucytosine Drugs for Serious Fungal Infections Fludarabine Chemotherapy Drugs Fludrocortisone Orthostatic Hypotension: Treatment Addison's Disease: Treatment Fluid retention see Swelling (edema...
|
|
|
Prostate cancer: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library
Prostate cancer: Treatment - Health Professional Information [NCI PDQ] This information is produced and provided by the National Cancer Institute (NCI).
Short-term results in these patients are similar to those for radical prostatectomy or external-beam radiation therapy.[ 25 , 26 , 27 ][Level of evidence: 3iiiDiii] One advantage is that the implant is performed as outpatient...
|
|
|
Results -- View
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
|
|
|
Results -- View
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
|
|
|
BioPortfolio Limited BioSeeker
Some of the drugs included in the report: Avodart, Zoladex, Proscar, Casodex, Taxotere, Satraplatin, Plenaxis, EULEXIN, Trelstar Depot, Trelstar LA, Viadur, Gleevec, Avastin, Herceptin, Atrasentan, Acapodene, Actimid, OSI-461, Revimid, Eladem, GTI-2501, ILX-651, calcitrol, Genasense, Provenge , GVAX, SGN-15, Thalomid, Velcade, Lupron Depot, Histrelin, Eligard, ILX651, Vitaxin, J591,...
|
|
|
AstraZeneca Half Year Results 2002-General Presentation
June 2002 Data Zyprexa ® Seroquel ® Risperdal ® Geodon ® Clozaril ® Market share Seroquel ® : US NRx in anti-psychotic market 0% 5% 10% 15% 20% 25% 30% 35% Jun-99 Jul-99 Aug-99 Sep-99 Oct-99 Nov-99 Dec-99 Jan-00 Feb-00 Mar-00 Apr-00 May-00 Jun-00 Jul-00 Aug-00 Sep-00 Oct-00 Nov-00 Dec-00 Jan-01 Feb-01 Mar-01 Apr-01 May-01 Jun-01 Jul-01 Aug-01 Sep-01 Oct...
|
|
|
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Release Teva Announces Approval of Flutamide Capsules Jerusalem, Israel, September 19, 2001 - Teva Pharmaceutical Industries Ltd.
Food and Drug Administration (FDA) has issued final approval for the Company’s ANDA for Flutamide Capsules.
Flutamide Capsules are the generic equivalent of Schering Corp’s antineoplastic...
|
|
|
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Releases Teva Announces Final Approval of Lovastatin Tablets Jerusalem, Israel, December 17, 2001 Teva and Proneuron Biotechnologies Entered into an Agreement to Develop glatiramer acetate for Multiple Neurodegenerative Diseases Jerusalem, Israel, December 4, 2001 Teva not Acquiring Faulding Injectable Business Jerusalem, Israel, November 14, 2001 Teva...
|
|
|
rsred-98 Eng 7
1 19 99 98 8 A AN NN NU UA AL L R RE EP PO OR R C CO ON N E EN N S S ANNUAL GENERAL MEETING AND CHEDULED INFORMATION 1 1 THI BIO 2 2 1998 IN BRIEF 3 3 TATEMENT BY THE PRE IDENT 4 4 THE MARKET 6 6 OBJECTIVE TRATEGY 9 9 KARO BIO' DI COVERY Y TEM 1 1 2 2 KARO BIO' EARCH PROGRAM 1 1 6 6 PER ONNEL AND ORGANIZATION 2 2 4 4 THE KARO BIO HARE AND OWNER HIP TRUCTURE 2 2 5 5 FIVE YEAR REVIEW 2...
author: Nina Evers
|
|
|
IROA - Scientific Study Reference Search
Pellets 2-Acetamidofluorene (2-AAF) 2-Acetylaminofluorene (AAF) 2-OHE1 3,3',5-Triiodo-L-Thyronine (T3) 4-Hydroxyandrostene-3,17-dione (4-OHA) 4-Hydroxyandrostenedione 5a-Androstan-3a + 17ss-diol 5a-Dihydrotestosterone (5a-DHT) 5a-Dihydrotestosterone (5a-DHT) 5a-Reductase Inhibitor (4MA) 5-Bromo-2'-Deoxyurdine (BrDU) 5a-Dihydrotestosterone (5a-DHT) 6-n-Propyl-2-Thiouracil (PTU...
|
|
|
Pellets for Immuno
- Testosterone, 5α -Dihydrotestosterone, Flutamide and Cyproterone Acetate Pellets for Tumor Growth and Regression in Immuno-Deficient Mice - It has been established that the growth and regression of androgen-dependent tumor tissue in mice is dependent upon three factors: 1.
The most commonly used 60-day and 90-day pellets in mice are listed below in these charts: 60 -...
|
|
|
Pellets for Immuno
278J Progress in Cancer Research & Therapy, 35:430-435 1988 - - Testosterone, 5α -Dihydrotestosterone, Flutamide and Cyproterone Acetate Pellets for Tumor Growth and Regression in Immuno-Deficient Mice - It has been established that the growth and regression of androgen-dependent tumor tissue in mice is dependent upon three factors: 1.
The most commonly used 60-day and...
|
|
|
2-Hydroxy-flutamide - LKT-H9718
- - For Pricing Information click here and submit your country
LKT-H9718 2-Hydroxy-flutamide [LKT] - Main Category: Antitumor Reagents Related Categories: - General: Product-ID LKT-H9718 Product Name 2-Hydroxy-flutamide Product Numbers / Sizes: LKT-H9718-M010 10 mg - - LKT-H9718-M025 25 mg - - LKT-H9718-M100 100 mg - - Original Manufacturer: LKT Laboratories, Inc
Product...
|
|
|
Immunology & Cancer Research
- - - Family view Immunology & Cancer Research ------- Angiogenesis ------------ Angiogenesis Modulators ------------ Angiopoietins and Tie Receptors ------------ Basic Fibroblast Growth Factor ------------ Bone Morphogenetic Protein 2 ------------ Cyclooxygenase 2 [COX-2] ----------------- Cyclooxygenases [COX]/Related Products ---------------------- Enzymes and Antibodies ---------...
|
|
|
Flutamide - LKT-F4680
- - For Pricing Information click here and submit your country
LKT-F4680 Flutamide [LKT] - Main Category: Antitumor Reagents Related Categories: - General: Product-ID LKT-F4680 Product Name Flutamide Product Numbers / Sizes: LKT-F4680-G001 1 g - - LKT-F4680-G005 5 g - - Original Manufacturer: LKT Laboratories, Inc
Product Specifications: - C11H11F3N2O3 MW: 276.2 CAS 13311-84-7...
|
|
|
http://www.adis.com/files/newsletters/PT/PTcov66.pdf
4 Iopentol: Stevens- Johnson syndrome [ S] 9 Pneumococcal vaccination reduces racial disparities 4 Lithium: pseudotumour cerebri [S] 9 Quinine vs artesunate in moderately severe malaria 5 Loperamide: anaphylaxis [ S] 10 Methylprednisolone/ prednisolone: Pneumocystis Research & Development carinii pneumonia [S] 10 Clindamycin ± fosmidomycin in paediatric malaria 6 Minocycline:...
|
|
|
http://www.adis.com/files/newsletters/INP/Icov1438.pdf
24 Protease inhibitors: clinical efficacy reviewed 3 CANCER Quinine vs artesunate in moderately severe malaria 15 Aspirin offers no pancreatic cancer protection 13 Ribavirin/ PEG- interferon- - 2a approved in Canada 22 BCG (intravesical) vs mitomycin in high- risk bladder cancer 10 Varivax vs ProQuad and M- M- R II in children 8 Bleomycin vs IFN- - 2b for metastatic pleural effusion...
|
|
|
Antitumor Reagents
- - - Family view Antitumor Reagents Items 90-100 of 232 Page 10 of 24 Select page: << - 6 - 7 - 8 - 9 -10- 11 - 12 - 13 - 14 - 15 - >> - Prod
Prod
Name Brand - LKT-E7329 Ethoxyquin LKT ALX-270-209 Etoposide ALEXIS LKT-E7657 Etoposide LKT LKT-E7668 Etretinate LKT LKT-E9317 Exemestane LKT LKT-F4557 Floxuridine LKT LKT-F4680 Flutamide LKT LKT-F5769 Formestane LKT ALX-380-065...
|
|
|
Paragraph IV Patent Certifications
- DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
|
